Clinical trials
Coronavirus Infections trials in Russia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 3 |
| Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 2 |
| Artgen Biotech | 1 |
| Chita State Regional Clinical Hospital Number 1 | 1 |
| City Clinical Hospital No.52 of Moscow Healthcare Department | 1 |
| St. Petersburg Research Institute of Vaccines and Sera | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 9 |
| COVID-19 | 5 |
| Pneumonia, Viral | 1 |
| Respiratory Tract Infections | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.